Following a full submission
AWMSG advice |
|||
Status: Recommended | |||
Tirbanibulin (Klisyri®) is recommended as an option for use within NHS Wales for the field treatment of non hyperkeratotic, non hypertrophic actinic keratosis (Olsen grade 1) of the face or scalp in adults. |
|||
|
|||
Medicine details |
|||
Medicine name | tirbanibulin (Klisyri®) | ||
Formulation | 10 mg/g ointment | ||
Reference number | 4076 | ||
Indication | For the field treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis (Olsen grade 1) of the face or scalp in adults |
||
Company | Almirall Ltd | ||
BNF chapter | Skin | ||
Submission type | Full | ||
Status | Recommended | ||
Advice number | 0122 | ||
NMG meeting date | 05/01/2022 | ||
AWMSG meeting date | 09/02/2022 | ||
Date of issue | 23/02/2022 |